ReviewFrontiers in oncology2025

HER2 alterations in non-small cell lung cancer (NSCLC): from biology and testing to advances in treatment modalities.

Ahmed Ismail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.